betacoronaviru
respons
diseas
first
describ
wuhan
china
late
swiftli
made
way
around
world
result
excess
death
date
effort
recogn
infect
focus
respiratori
symptom
cough
short
breath
current
center
diseas
control
prevent
cdc
criteria
identifi
person
investig
infect
unit
state
compris
respiratori
symptom
andor
fever
recent
report
china
describ
concomit
digest
symptom
nausea
vomit
diarrhea
abdomin
pain
patient
confirm
pulmonari
infect
presenc
rna
fecal
sampl
howev
remain
unclear
whether
digest
symptom
causal
relat
gastrointestin
infect
main
goal
care
case
treat
pulmonari
diseas
limit
healthcar
worker
exposur
comprehens
evalu
gastrointestin
system
implic
viru
rule
altern
etiolog
undertaken
present
case
gastrointestin
infect
caus
acut
hemorrhag
coliti
signal
diseas
endoscopi
confirm
colon
injuri
help
exclud
etiolog
diseas
believ
observ
import
implic
detect
transmiss
diseas
woman
histori
hypertens
depress
chronic
back
pain
return
unit
state
earli
march
trip
egypt
includ
cruis
nile
river
last
day
egypt
develop
diffus
abdomin
pain
nonbloodi
diarrhea
next
day
travel
back
unit
state
diarrhea
becam
bloodi
next
day
experienc
nausea
vomit
anorexia
diffus
abdomin
pain
distent
bloodi
bowel
movement
daili
present
emerg
depart
day
onset
symptom
physic
examin
reveal
temperatur
blood
pressur
mm
hg
puls
beat
per
minut
respiratori
rate
breath
per
minut
oxygen
satur
ambient
air
lung
auscult
normal
abdomin
examin
demonstr
normal
bowel
sound
diffus
tender
palpat
sign
periton
red
blood
mix
loos
stool
present
bedsid
commod
question
deni
fever
cough
short
breath
sore
throat
symptom
also
deni
person
famili
histori
gastrointestin
diseas
undergon
normal
screen
colonoscopi
month
earlier
deni
antibiot
antidiarrh
nonsteroid
antiinflammatori
use
food
allergi
lactos
intoler
alcohol
abus
smoke
drug
use
medic
includ
lisinopril
desvenlafaxin
amlodipin
morphin
need
chronic
back
pain
report
vaccin
hepat
b
laboratori
evalu
notabl
elev
white
blood
cell
count
kml
kml
neutrophil
normal
lymphocyt
eosinophil
distribut
normal
hemoglobin
slightli
elev
creatinin
mgdl
baselin
mgdl
ct
scan
abdomen
pelvi
intraven
contrast
show
sever
colon
inflamm
pronounc
ascend
transvers
descend
colon
also
appar
sigmoid
colon
figur
also
small
right
pleural
effus
given
presumpt
diagnosi
travel
diarrhea
dysenteri
empir
ceftriaxon
azithromycin
metronidazol
initi
intraven
administr
antimicrobi
fecal
sampl
obtain
neg
fecal
leukocyt
stool
cultur
campylobact
salmonella
shigella
shiga
toxinproduc
escherichia
coli
yersinia
ova
parasit
clostridium
difficil
toxin
glutam
dehydrogenas
antigen
toxin
screen
next
day
anoth
fecal
sampl
neg
entamoeba
histolytica
antigen
giardia
antigen
note
later
hospit
hospit
day
fecal
molecular
test
filmarray
biofir
diagnost
salt
lake
citi
ut
also
neg
bacteri
viral
parasit
pathogen
human
immunodefici
viru
antibodi
legionella
urin
antigen
also
neg
next
day
patient
abdomin
pain
bloodi
diarrhea
persist
despit
antimicrobi
support
given
concern
inflammatori
bowel
diseas
creactiv
protein
hospit
day
mgdl
addit
hospit
day
patient
learn
someon
travel
group
diagnos
pulmonari
infect
patient
immedi
move
negativepressur
room
precaut
institut
hospit
day
day
onset
digest
symptom
patient
develop
cough
nasopharyng
swab
sent
comprehens
viral
detect
includ
rna
quest
diagnost
given
patient
elev
creactiv
protein
persist
abdomin
pain
bloodi
diarrhea
flexibl
sigmoidoscopi
perform
hospit
day
evalu
evid
inflammatori
bowel
diseas
ischem
coliti
endoscop
evalu
cm
anal
verg
reveal
patchi
area
focal
erythema
without
ulcer
descend
colon
sigmoid
colon
rectum
figur
histolog
examin
colon
rectal
biopsi
hematoxylin
eosin
stain
light
microscopi
show
slight
expans
lamina
propria
edema
normal
cellular
intact
crypt
virocyt
protozoa
seen
microscop
chang
indic
presenc
classic
infecti
coliti
ischemia
inflammatori
bowel
diseas
even
hospit
day
patient
nasopharyng
swab
comprehens
respiratori
viral
panel
return
posit
rhinoviru
herp
simplex
viru
rna
also
posit
revers
transcriptas
polymeras
chain
reaction
next
sever
day
patient
abdomin
pain
bloodi
diarrhea
persist
sore
throat
develop
hospit
day
revers
transcriptas
polymeras
chain
reaction
perform
fecal
sampl
use
swab
viral
transport
media
nasopharyng
test
kit
also
posit
hospit
day
patient
respiratori
statu
worsen
oxygen
satur
declin
ambient
air
given
two
mg
dose
hydroxychloroquin
follow
mg
twice
daili
within
next
hour
improv
abdomin
pain
bloodi
diarrhea
respiratori
symptom
evolv
requir
l
oxygen
via
nasal
cannula
sever
day
ct
scan
chest
ct
angiogram
abdomen
pelvi
perform
hospit
day
show
multifoc
pneumonia
consist
pulmonari
diseas
resolut
colon
inflamm
figur
evid
vascular
compromis
next
day
patient
respiratori
statu
gradual
improv
wean
oxygen
supplement
digest
symptom
also
improv
patient
discharg
hospit
day
good
health
antimicrobi
unfortun
time
write
report
patient
readmit
mental
statu
chang
current
evalu
grow
appreci
import
digest
symptom
nausea
vomit
anorexia
nonbloodi
diarrhea
abdomin
pain
spectrum
diseas
presum
gastrointestin
manifest
report
anywher
patient
concomit
pulmonari
infect
rna
found
fecal
sampl
patient
pulmonari
diseas
initi
case
seri
note
patient
eventu
found
pulmonari
infect
initi
present
isol
digest
symptom
difficult
establish
whether
infect
directli
respons
digest
symptom
focu
care
hospit
patient
respiratori
ill
endoscopya
possibl
virusaerosol
procedurei
use
judici
diagnost
studi
implic
viru
gastrointestin
patholog
exclud
etiolog
gener
undertaken
patient
present
bloodi
diarrhea
previous
describ
manifest
index
suspicion
earli
march
low
patient
undergo
comprehens
evalu
strongli
suggest
gastrointestin
infect
respons
acut
hemorrhag
coliti
demonstr
rna
present
patient
fece
endoscop
find
coloproctopathi
descend
colon
sigmoid
colon
rectum
confirm
colon
injuri
point
toward
infecti
process
also
abl
elimin
greatest
extent
possibl
potenti
etiolog
hemorrhag
colitissuch
altern
infect
inflammatori
bowel
diseas
ischem
colitisthrough
laboratori
test
radiolog
imag
colon
rectal
biopsi
although
fecal
molecular
test
perform
initi
antimicrobi
well
describ
even
treat
patient
fecal
molecular
test
remain
posit
sever
week
combin
fact
patient
improv
standard
antimicrobi
therapi
make
multiinfect
scenario
unlik
interestingli
although
patient
endoscop
evid
coloproctopathi
colon
thicken
ct
sigmoid
colon
rectal
biopsi
histolog
unremark
current
commerci
avail
assay
unit
state
test
tissu
presenc
rna
abl
howev
normal
histolog
find
line
sarscov
experi
wherein
light
microscopi
small
intestin
colon
specimen
patient
confirm
sarscov
gastrointestin
infect
show
normal
architectur
without
evid
villou
atrophi
inflammatori
infiltr
virocyt
also
access
electron
microscopi
sarscov
experi
viral
particl
seen
electron
microscopi
small
intestin
colon
epitheli
cell
similarli
also
disconnect
degre
colon
inflamm
seen
initi
ct
scan
endoscop
observ
coloproctopathi
seen
flexibl
sigmoidoscopi
suspect
ct
scan
perform
day
flexibl
sigmoidoscopi
thu
heal
like
alreadi
take
place
least
left
colon
moreov
ct
scan
colon
inflamm
pronounc
ascend
transvers
colon
left
colon
far
behind
patient
continu
bloodi
diarrhea
flexibl
sigmoidoscopi
like
resolv
mucos
damag
ascend
transvers
colon
observ
flexibl
sigmoidoscopi
establish
target
viral
receptor
angiotensinconvert
enzym
receptor
highli
express
type
ii
alveolar
cell
esophagu
epitheli
cell
small
intestin
colon
cell
among
cell
type
addit
immunofluoresc
analysi
shown
receptor
abundantli
express
gastric
rectal
epithelia
data
suggest
may
gain
entri
potenti
damag
gastrointestin
host
cell
caus
array
digest
symptom
current
observ
patient
take
lisinopril
mg
daili
part
regimen
hypertens
report
suggest
patient
treat
ace
inhibitor
angiotensin
receptor
blocker
may
theoret
increas
number
receptor
make
prone
infect
perhap
higher
risk
sever
diseas
certainli
plausibl
appli
patient
patient
clinic
improv
hydroxychloroquin
administr
report
suggest
possibl
benefit
unsur
whether
truli
therapeut
effect
coincident
research
certainli
need
regard
clinic
efficaci
hydroxychloroquin
treatment
infect
transmiss
perspect
oral
respiratori
droplet
well
describ
major
mode
transmiss
viral
particl
howev
live
viru
also
isol
fecal
sampl
viral
particl
detect
fece
even
resolut
respiratori
symptom
suggest
potenti
fecalor
transmiss
beyond
symptomat
period
patient
admit
meet
cdc
guidelin
time
person
investig
infect
afebril
respiratori
symptom
travel
china
itali
iran
south
korea
unfortun
awar
washington
post
articl
ran
day
present
report
cluster
case
associ
nile
river
cruis
awar
gastrointestin
manifest
may
increas
index
suspicion
encourag
us
institut
precaut
arriv
avoid
exposur
subsequ
quarantin
healthcar
worker
includ
mani
us
knowledg
first
report
gastrointestin
infect
caus
hemorrhag
coliti
colon
injuri
demonstr
endoscop
etiolog
exclud
case
add
bodi
evid
implic
gastrointestin
tract
clinic
express
transmiss
infect
basi
believ
import
institut
precaut
patient
present
either
respiratori
digest
symptom
also
encourag
rapid
develop
deploy
fecal
test
kit
rna
encourag
institut
use
nasopharyng
kit
fecal
test
interim
march
new
york
citi
healthcar
profession
made
recommend
anyon
present
new
york
citi
hospit
even
without
respiratori
digest
symptom
consid
posit
appropri
safeguard
taken
reach
level
univers
countri
yet
howev
emerg
diseas
continu
evolv
must
maxim
hear
hoofbeat
think
hors
zebra
work
well
unless
safarior
middl
pandem
guarantor
articl
anthoni
debenedet
md
msc
specif
author
contribut
ac
report
concept
acquisit
data
analysi
interpret
data
draft
final
manuscript
ra
report
concept
acquisit
data
analysi
interpret
data
draft
final
manuscript
aa
report
concept
acquisit
data
analysi
interpret
data
draft
final
manuscript
mp
report
concept
acquisit
data
analysi
interpret
data
draft
final
manuscript
nk
acquisit
data
intellectu
manuscript
revis
sp
acquisit
data
intellectu
manuscript
revis
atd
report
concept
acquisit
data
analysi
interpret
data
draft
final
manuscript
financi
support
none
report
potenti
compet
interest
none
report
